BCYC Bicycle Therapeutics plc
Healthcare$4.57+0.44%ClosedMarket Cap: $316.5M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.57
P/S
4.96
EV/EBITDA
1.09
DCF Value
$-99.45
FCF Yield
-72.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
-11.9%
Operating Margin
-381.8%
Net Margin
-345.0%
ROE
-35.7%
ROA
-33.6%
ROIC
-40.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $887.0K | 100.0% | $-65.6M | $-60.8M | $— | — |
| Q4 null | $48.0M | 100.0% | $-24.7M | $-20.2M | $— | — |
| FY null | $72.6M | 100.0% | $-247.7M | $-219.0M | $— | — |
| Q3 null | $11.7M | 100.0% | $-65.6M | $-59.1M | $— | — |
| Q2 null | $2.9M | -2332.5% | $-86.6M | $-79.0M | $— | — |
| Q1 null | $10.0M | -474.0% | $-70.2M | $-60.8M | $— | — |
| Q4 null | $3.7M | -1412.2% | $-67.7M | $-51.9M | $— | — |
| FY null | $35.3M | -390.3% | $-209.9M | $-169.0M | $— | — |
| Q3 null | $2.7M | -1605.8% | $-63.8M | $-50.8M | $— | — |
| Q2 null | $9.4M | 100.0% | $-46.6M | $-39.8M | $— | — |
| Q1 null | $19.5M | 100.0% | $-31.7M | $-26.6M | $— | — |
| Q4 2023 | $5.3M | 100.0% | $-54.2M | $-49.1M | $-1.16 | — |